← All Ensysce Biosciences, INC filings

Ensysce Biosciences, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ENSC
Ensysce Biosciences, INC
10-K: Ensysce Biosciences Reports Full Year 2024 Results, Highlights Clinical Progress and Financial Position
Ensysce Biosciences details its financial results for 2024 and provides an update on its clinical development programs focused on pain relief and abuse prevention.
NASDAQ
ENSC
Ensysce Biosciences, INC
10-K: Ensysce Biosciences Reports 2023 Financial Results and Provides Business Update
Ensysce Biosciences, a clinical-stage pharmaceutical company, released its 2023 annual report, detailing financial performance and progress in its drug development programs.